Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung
Conditions
Interventions
Intervention1: Phlebotomy: Single time Collection of 5ml venous or arterial blood from newly diagnosed lung cancer patient and laboratory assessment of various biochemical and biophysical parameters
C
Sponsors
Pranav Menon
Eligibility
Inclusion criteria
Inclusion criteria: Patients with primary lung cancer who have been newly diagnosed and confirmed by histopathological examination Patients providing valid informed consent
Exclusion criteria
Exclusion criteria: Patient with unknown primary malignancy and extensive metastasis Diagnosed patient on chemotherapy Patients unwilling to provide valid informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase in oxidative stress secondary to cancer induced inflammatory milieuTimepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Conformational change in human serum albumin secondary to prevailing oxidative stressTimepoint: 2 years | — |
Countries
India
Contacts
Public ContactZarina Arif
Jawaharlal Nehru medical college hospital, Aligarh Muslim University, Aligarh
Outcome results
None listed